We are live on
!
Find out more
Ensign Peak Advisors Portfolio holdings
AUM
$53.7B
1-Year Est. Return
29.47%
This Fund
S&P 500
This Quarter
Est. Return
+12.76%
1 Year Est. Return
+29.47%
3 Year Est. Return
+102.45%
5 Year Est. Return
+139.11%
10 Year Est. Return
–
AUM
$50.5B
AUM Growth
+$3.68B
(+7.8%)
Cap. Flow
-$1.47B
Cap. Flow
% of AUM
-2.92%
Top 10 Holdings %
Top 10 Hldgs %
27.58%
Holding
1,779
New
23
Increased
1,010
Reduced
375
Closed
40
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Estee Lauder
EL
|
+$137M |
| 2 |
Crown Castle
CCI
|
+$132M |
| 3 |
Advanced Micro Devices
AMD
|
+$117M |
| 4 |
Thermo Fisher Scientific
TMO
|
+$113M |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$98.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walmart Inc
WMT
|
+$215M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$200M |
| 3 |
UnitedHealth
UNH
|
+$183M |
| 4 |
Apple
AAPL
|
+$133M |
| 5 |
AstraZeneca
AZN
|
+$121M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.26% |
| 2 | Healthcare | 15.74% |
| 3 | Financials | 12.66% |
| 4 | Consumer Discretionary | 9.73% |
| 5 | Industrials | 7.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CVGW
1651
DELISTED
Calavo Growers
CVGW
| $519K | ﹤0.01% |
17,652
| – | – |
|
1652
Lindblad Expeditions
LIND
$1.84B
| $517K | ﹤0.01% |
45,870
+8,950
| +24% | +$69.4K |
|
1653
Relay Therapeutics
RLAY
$4.06B
| $516K | ﹤0.01% |
46,850
+7,950
| +20% | +$67.1K |
|
1654
Varex Imaging
VREX
$463M
| $515K | ﹤0.01% |
25,125
+1,150
| +5% | +$22K |
|
1655
National Presto Industries
NPK
$896M
| $514K | ﹤0.01% |
6,400
+800
| +14% | +$61.5K |
|
|
HSII
1656
DELISTED
Heidrick & Struggles
HSII
| $506K | ﹤0.01% |
17,150
+4,400
| +35% | +$117K |
|
1657
Ameresco
AMRC
$1.12B
| $502K | ﹤0.01% |
15,840
+3,200
| +25% | +$96.5K |
|
1658
Compañía de Minas Buenaventura
BVN
$8.06B
| $487K | ﹤0.01% |
31,950
| – | – |
|
1659
ACM Research
ACMR
$5.53B
| $487K | ﹤0.01% |
24,910
+1,250
| +5% | +$21.9K |
|
1660
ATN International
ATNI
$364M
| $484K | ﹤0.01% |
12,424
+1,200
| +11% | +$39.6K |
|
1661
Pliant Therapeutics
PLRX
$66.9M
| $484K | ﹤0.01% |
26,700
+9,250
| +53% | +$141K |
|
1662
Pediatrix Medical
MD
$2.15B
| $483K | ﹤0.01% |
51,949
+10,550
| +25% | +$109K |
|
1663
World Kinect Corp
WKC
$2.04B
| $476K | ﹤0.01% |
20,901
-1,700
| -8% | -$35.7K |
|
|
PRA
1664
DELISTED
ProAssurance
PRA
| $475K | ﹤0.01% |
34,430
+2,600
| +8% | +$39.8K |
|
1665
Legend Biotech
LEGN
$3.73B
| $472K | ﹤0.01% |
7,850
| – | – |
|
1666
NewAmsterdam Pharma Warrant
NAMSW
$87.4M
| $470K | ﹤0.01% |
150,000
| – | – |
|
|
NFBK
1667
DELISTED
Northfield Bancorp
NFBK
| $468K | ﹤0.01% |
37,200
+9,450
| +34% | +$95K |
|
1668
HealthStream
HSTM
$814M
| $468K | ﹤0.01% |
17,310
| – | – |
|
1669
E.W. Scripps
SSP
$271M
| $464K | ﹤0.01% |
58,134
+12,800
| +28% | +$86.1K |
|
|
MDRX
1670
DELISTED
Veradigm Inc. Common Stock
MDRX
| $462K | ﹤0.01% |
44,050
| – | – |
|
1671
DXP Enterprises
DXPE
$2.57B
| $460K | ﹤0.01% |
13,650
+3,100
| +29% | +$101K |
|
1672
State Street Industrial Select Sector SPDR ETF
XLI
$33.4B
| $458K | ﹤0.01% |
4,022
-873
| -18% | -$91.6K |
|
1673
Harmony Biosciences
HRMY
$2.08B
| $454K | ﹤0.01% |
14,060
+2,350
| +20% | +$65.6K |
|
1674
Atlanta Braves Holdings Series B
BATRK
$3.25B
| $453K | ﹤0.01% |
11,438
+9,550
| +506% | +$348K |
|
1675
OraSure Technologies
OSUR
$273M
| $452K | ﹤0.01% |
55,168
| – | – |
|
Similar funds
SCP
Ensign Peak Advisors's Q4 2023 Portfolio in Review
As of Q4 2023, Ensign Peak Advisors held 1,779 positions worth $50.5B, up 7.8% from $46.8B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Trading was light in Q4 2023: portfolio turnover was 3.5%. Ensign Peak Advisors opened 23 new positions and exited 40, leaving the 1,779-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.
- Ensign Peak Advisors's largest Q4 2023 buy was State Street SPDR S&P 500 ETF Trust: 140,000 shares worth $66.5M.
- Ensign Peak Advisors added most to Estee Lauder in Q4 2023, an estimated $137M increase.
- Ensign Peak Advisors's biggest Q4 2023 reduction was Walmart Inc, cutting an estimated $215M.
- Ensign Peak Advisors fully exited Invesco QQQ Trust in Q4 2023, selling an estimated $57.3M.
- Ensign Peak Advisors's ten largest holdings make up 28% of its $50.5B portfolio in Q4 2023.
- Ensign Peak Advisors opened 23 new positions and closed 40 in Q4 2023.
- Ensign Peak Advisors's portfolio value rose 7.8% quarter-over-quarter to $50.5B.
Based on Ensign Peak Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.